Company Snapshot
Capital Southwest Corporation | NASDAQ: CSWC | Focus: dividend | Type: internally managed BDC | Currency: USD
Updated November 4, 2026. Assessment author: ChatGPT. Complete fiscal Q2 2027 results cover the quarter ended September 30, 2026, released November 2; the earnings call was held November 3. Assessment follows Investment Analysis Rules, methodology 1.2.
Results confirm CSWC's strong origination and lending platform: record new commitments of USD 391 million, NAV of USD 16.64 and higher UTI of USD 0.92 per share. However, credit quality deteriorated and leverage reached the upper end of its target. Analytical conclusion: the quality dividend BDC thesis remains valid, but asset growth has not yet created a safe dividend cushion. Business strength remains 7.2/10; at USD 23.25, attractiveness falls to 5.6/10. A premium of almost 40% to NAV limits room for disappointment. (T3; S9)
| Metric | Value and period |
|---|---|
| Business strength | 7.2/10, assessed November 4, 2026 |
| Price attractiveness | 5.6/10 at USD 23.25, quote November 3, 2026, assessed November 4, 2026 |
| Stock and price | CSWC common stock, NASDAQ; USD 23.25 closing price on November 3, 2026 at 16:00 EST, or 22:00 CET |
| NAV per share | USD 16.64 at September 30, 2026, versus USD 16.61 in June |
| Price/NAV | 1.40×; approximately 39.7% premium |
| September-quarter NII per share | USD 0.58 before tax; reported USD 0.56 after tax |
| Regular dividend | USD 0.58 quarterly, paid monthly at USD 0.1934 |
| Supplemental dividend | USD 0.06 quarterly, also declared for December 2026 |
| Annual payout run rate | Approximately USD 2.32 regular; USD 2.56 including supplements if continued |
| Gross yield at USD 23.25 | 10.0% regular; 11.0% including supplements |
| Base three-year scenario | Total return +28.8% in USD without dividend reinvestment |
| Adverse three-year scenario | Total return −16.6% in USD including dividends |
| Next quarterly results | Fiscal Q3 2027 ending December 31, 2026: date not yet researched — two months have not elapsed since the latest results. Status at November 4, 2026 under the shared methodology. |
Price: S8; dividends: S3 and T3; results: S9 and T3. Yields, multiples and scenarios are ChatGPT calculations. Annual payout run rate is not a promise of future dividends.
Dividend Investment Thesis
The dividend thesis rests on an efficient internally managed lending platform, portfolio quality and preservation of NAV per share. Regular income has value only when supported over time by NII and realized gains. Asset growth and a high payout rate alone do not guarantee greater shareholder value.
ChatGPT's main reservations are tight payout coverage and a premium of almost 40% to NAV. Improved financing and timely deployment of new capital must deliver per-share improvements; loss of the premium can erase a substantial part of the dividend return.
Business & Income Sources
Capital Southwest finances smaller and midsized US businesses, often in private-equity-led acquisitions. Revenue comes mainly from loan interest and fees; minority equity co-investments add potential realized gains. Loans generate recurring income, whereas equity exits can be irregular. (T1)
Competitive Advantages
Internal management is a documented advantage: trailing-twelve-month operating expenses relative to assets remain 1.4%, versus 1.6% a year earlier. The company calls this “operating leverage”; it is not debt leverage. Management says the team grew from 27 to 46 people in 18 months and screened approximately 1,600 opportunities over the last twelve months. Wider reach and sponsor relationships support growth, but competition and lending-margin pressure persist. (T3)
Growth must be assessed per share. New issuance above NAV can increase book value attributable to existing shares, but management must invest the additional capital promptly and well. A larger portfolio alone does not guarantee a higher dividend.
Dividend Sustainability
The regular USD 0.58 quarterly dividend is split into monthly payments. The USD 0.06 supplement is a less predictable income component. Monthly payments of USD 0.1934 were declared for October through December; the December supplement is due on December 31, 2026. The small difference between three monthly amounts and the rounded USD 0.58 reflects rounding. (S3)
| Dividend coverage | June 2026 | September 2026 actual |
|---|---|---|
| Regular dividend covered by pre-tax NII | Approximately 98% | Approximately 100% |
| Regular dividend covered by reported after-tax NII | Approximately 100% | Approximately 97% |
| Total dividend covered by reported after-tax NII | Approximately 91% | Approximately 88% |
ChatGPT calculations from published rounded figures; NII is quarterly. Sources: S1, S9 and T3. NII coverage excludes realized capital gains and differences between accounting and taxable income.
Dividend conclusion: the regular payout still has a limited cushion, and total distributions are not covered by current accounting NII alone. The increase in UTI from USD 0.87 to USD 0.92 per share is positive and supports the ability to continue supplements. UTI is a tax measure of accumulated undistributed income, not a separate cash reserve or additional value above NAV. Management's 109% cumulative coverage since 2015 does not establish coverage for the current individual quarter. (T3)
A BDC's taxable income can differ from accounting NII. One weaker quarter therefore does not automatically imply a dividend cut. Persistently distributing more than NII and realized gains would, however, damage NAV. The dividend designation here describes the investment focus.
Loan Portfolio & Earnings Quality
| Metric | March 2026 | June 2026 | September 2026 actual |
|---|---|---|---|
| Period-end NAV | USD 16.69 | USD 16.61 | USD 16.64 |
| Quarterly pre-tax NII per share | USD 0.59 | USD 0.57 | USD 0.58 |
| Quarterly after-tax NII per share | — | USD 0.58 | USD 0.56 reported |
| Regular quarterly dividend | USD 0.58 | USD 0.58 | USD 0.58 |
| Total quarterly dividend | USD 0.64 | USD 0.64 | USD 0.64 |
| Period-end UTI per share | USD 1.07 | USD 0.87 | USD 0.92 |
| Non-accruals at fair value | 1.1% | 1.1% | 1.4% |
| Regulatory debt leverage | 0.90× | 0.91× | 1.00× |
Sources: S1, S7, S9 and T3. A dash indicates a figure not supplied in this table. Fiscal Q1 2027 ends in June 2026, Q2 2027 in September 2026. September figures replace the October 15 preliminary estimate.
September investment income rose to USD 67.2 million from June's USD 61.0 million, approximately 10% sequentially. Pre-tax NII rose to USD 37.2 million, but per-share NII only from USD 0.57 to USD 0.58. New commitments reached USD 391 million; these are contractually committed investments, not automatically cash already fully disbursed. The loan portfolio reached approximately USD 2.2 billion, up 28% year over year. Origination improvement is more convincing than income growth per share so far. (T3)
Earnings quality: income growth was supported by cash interest and higher fees from record transaction volume. PIK, interest added to debt instead of received in cash, fell from 8.0% to 7.4% of income. This is a sequential improvement, not evidence that all of the remaining 92.6% is pure cash profit. One-off shareholder-proxy solicitation costs of approximately USD 0.4 million equal roughly USD 0.006 per average share before tax; removing them alone does not close the gap to the USD 0.64 total dividend. (T3; S9, ChatGPT calculation)
NAV rose only USD 0.03 per share, primarily through issuance above book value. Stable NAV therefore should not be confused with an absence of credit losses. After-tax accounting NII and the total change in net assets have different meanings; loan marks and realizations can materially affect the latter. (T3; S9)
What the analyst discussion added
| Topic and question | Management response | Thesis impact and further verification |
|---|---|---|
| Mickey Schleien, Clear Street: write-down sources and leverage | Sarner attributes approximately USD 10 million of depreciation to three companies: a car wash, roofing roll-up and post-production CGI business. Rehberger confirms a 0.9–1.0× regulatory leverage target. | Risks are specific; their isolation is management's claim. Verify further non-accruals and actual recoveries. |
| Melissa Wedel, UBS: why two JVs and higher repayments | CapTrin finances CSWC's own lending strategy; Desert Star provides access to Trinity's technology lending. Management expects more repayments in the December quarter. | Repayments can reduce leverage but also constrain net growth of earning assets. The JVs are distinct strategies. |
| Robert Dodd, Raymond James: software expertise and UTI | CSWC shares JV decision-making; Trinity supplies technology expertise. Sarner calls UTI around USD 1 strong and USD 0.50 or below weak for the USD 0.06 supplement. | Desert Star is limited exposure with partner risk. UTI is a monitoring measure, not a promise of supplements. |
| Sean-Paul Adams, B. Riley: consumer pressure | Weinstein also cites local overbuilding and capital structure for car washes, and storms and acquisition execution for roofing. | Weakness cannot be explained solely by interest rates. Monitor borrowers' operational repair. |
Source: T3, Q&A on November 3, 2026. Possible growth in regular and supplemental dividends in 2027 reflects management optimism, not an approved payout or binding guidance.
As of September, management reports 153 portfolio companies, average exposure of approximately 0.8%, and private equity sponsorship for around 92% of the loan portion. First lien represents about 99% of loans and 89.4% of all investments; the remainder includes equity and JVs. Loan yield remained 10.9%, with average borrower leverage through CSWC's position of 3.7× EBITDA. New deals had an average spread of 6.5 percentage points, senior leverage of 3.4× and LTV of 33%. Diversification and collateral do not guarantee repayment. (T3)
Credit quality deteriorated modestly: non-accruals rose from 1.1% to 1.4% of the entire portfolio at fair value and from 2.9% to 3.5% at cost. Their September fair value was USD 34.8 million against cost of USD 85.5 million. The lower fair-value measure already reflects prior write-downs. Management attributes most new depreciation to three specific companies; future restructuring results must confirm that explanation. (S9; T3)
Regulatory leverage rose from 0.91× to 1.00×, reaching the top of management's 0.9–1.0× target. Economic balance-sheet leverage including SBA is around 1.25× according to the discussion; JV debt adds another risk layer. Cash and undrawn facilities rose to approximately USD 647 million against USD 394 million of unfunded portfolio commitments. Not all of this is free cash: some is conditional borrowing capacity. The first maturities are not until 2029. (T3)
Key KPIs
| Event or metric | What matters |
|---|---|
| December quarter 2026 | Whether expected repayments reduce regulatory leverage into the 0.9–1.0× range and how they affect net portfolio growth |
| NII and its quality | After-tax regular-dividend coverage, PIK and repeatability of fees following the record quarter |
| Credit problems | Developments in car washes, roofing businesses and CGI; non-accruals at both valuations and actual recoveries |
| UTI and realized gains | Whether the USD 0.92 balance grows further; potential larger exits in 2027 are management expectations |
| CapTrin and Desert Star | Capital drawn, actual dividend income and JV risk, not just target returns |
| Next quarterly results | Date not yet researched — two calendar months have not elapsed since the November 2, 2026 results |
Repayment and exit expectations come from T3 and are not guarantees of completed transactions. Under the methodology, active verification of the next earnings date begins no earlier than January 2, 2027.
Management, Balance Sheet & Capital
Capital changes and new investment structures:
- September 1: an increase in authorized shares from 75 million to 135 million was approved. This is an authorized ceiling, not an immediate issue of 60 million shares. (S6)
- September 2: the main credit facility increased to USD 595 million, the spread fell from 2.15 to 2.00 percentage points, and final maturity extended to September 2031. (S4)
- September notes: the USD 350 million issue with a 6.75% coupon and 2031 maturity was completed and helped repay the revolving facility. A simultaneous swap changes its economic interest cost to SOFR + approximately 2.16 percentage points. It is therefore incorrect to model all USD 350 million as funding with a fixed 6.75% cost. (T3; S9, S10)
- September 17: the SBA increased approved SBIC II capacity from USD 175 million to USD 250 million. Approved capacity is not debt already drawn. (S4b)
CapTrin and Desert Star play different roles. CapTrin expands CSWC's lower-spread lending opportunities through a first-out/last-out structure; it holds approximately USD 127 million of loans and CSWC's equity commitment is USD 50 million. Desert Star relies on technology loans sourced by Trinity; CSWC committed USD 25 million to be invested gradually over roughly three years. Target returns in the mid-teens are management forecasts, not sustained returns already achieved. Desert Star's small size limits the impact of failure but does not eliminate software-borrower risk. (T3)
In the September quarter, CSWC raised approximately USD 67 million through issuance at an average USD 24.50 price. The high premium therefore benefits existing shareholders' NAV. Per-share income growth requires new-investment contributions to outweigh dilution and write-downs; the market premium is not guaranteed to persist. (T3)
Risks / Bear Case
- Credit losses: first lien can suffer losses when borrower value falls; actual recoveries and write-downs matter.
- Interest rates: lower base rates can reduce loan yields; higher rates can impair borrowers' repayment capacity. The net effect on income, financing and losses is decisive.
- Growth without per-share benefits: issuance above NAV is an opportunity, but weak execution or credit losses can consume its positive effect.
- JVs and software loans: CapTrin adds structured leverage and different first-out/last-out seniority. Desert Star adds reliance on Trinity's technology expertise and software-borrower risks; the USD 25 million commitment is limited, not risk-free. (T3)
- Share repricing: at NAV of USD 16.64, a return to 1.10× NAV would imply approximately USD 18.30, about 21% below USD 23.25 even without further NAV decline.
Valuation & Total Return
ChatGPT produces the calculations and valuation scenarios. Share-price inputs are dated to the analysis; they are not continuously updated market data.
Different outcomes. Different values.
23.25 USD · November 3, 2026 · 16:00 EST · NASDAQ close
Price attractiveness: 5.6/10 at USD 23.25. Quote date: November 3, 2026, NASDAQ closing price for CSWC. Assessed on: November 4, 2026. Horizon: three years. Methodology: 1.2.
CSWC common stock is valued through future NAV per share and an appropriate NAV premium, cross-checked against NII and dividends. Debt is already reflected in net asset value and is not deducted again. Possible issuance, stock compensation and note conversions are included in assumed resulting per-share value and income. No exact future share count is forecast. EV/revenue is not the primary valuation method for this lending model.
The following scenarios are ChatGPT assumptions, not management guidance or consensus. Terminal NAV, multiples and total dividends remain unchanged from October 17: record new commitments alone do not justify a higher per-share value forecast. The base case assumes gradual NII growth and a CapTrin contribution; the adverse case includes recession, write-downs, payout cuts and loss of the premium. Both use three years from the current assessment.
| Item | Base case | Adverse case |
|---|---|---|
| Business assumptions | After-tax NII gradually reaches USD 2.40–2.50 annually per share; new investments and JVs outweigh financing costs and ordinary write-downs. | NII of USD 1.75–1.90 annually; higher credit losses, supplements end and the regular dividend falls. |
| NAV in three years | USD 17.50 per share, about 1.7% annual growth from September's USD 16.64 | USD 14.00 per share, about a 16% cumulative decline |
| Future valuation | 1.30× NAV; some platform premium remains | 1.00× NAV; premium disappears |
| Price in three years | USD 22.75 | USD 14.00 |
| Dividends over three years | USD 7.20, averaging USD 2.40 annually | USD 5.40, for example USD 2.00 + 1.70 + 1.70 |
| Total three-year return | +28.8% | −16.6% |
Calculation: (price in three years + total dividends) / 23.25 − 1. Dividends are not reinvested; returns exclude taxes, fees and USD/CZK changes. The base case corresponds to an approximately 8.8% annual equivalent of the final price-plus-dividend sum, not an IRR based on payment dates. The adverse scenario is not the worst possible loss.
The supplementary optimistic scenario retains NAV of USD 18.50, a 1.45× NAV valuation and USD 7.80 of dividends over three years. A USD 26.83 price implies approximately +48.9% in total from USD 23.25. It requires successful execution and a sustained high premium; it does not underpin the score.
- Brief rationale: the current payout run rate offers high income, but the buyer pays approximately 40% above NAV. Higher UTI supports supplements, while higher non-accruals and leverage limit outlook improvement. A slightly higher price and worse credit metrics reduce the score from 5.7 to 5.6/10; the base valuation is unchanged.
- Main weakness: sustainability of the NAV premium amid tight regular-dividend coverage and increasing credit problems.
- Assessment confidence: medium. Price is verified; future NAV, credit losses and the multiple are scenario assumptions.
- Condition for change: a price around USD 20–21 with credit quality intact would improve attractiveness. A price above USD 25 without NII and NAV growth would reduce it. Fundamental deterioration can outweigh a lower stock price.
Price bands
| Price | Meaning if the current thesis remains intact |
|---|---|
| USD 23–24 | Approximately fair to slightly expensive valuation; high NAV premium and limited dividend-coverage cushion |
| USD 20–21 | First band for reassessment; about 1.20–1.26× September NAV |
| USD 18–19 | A greater price cushion; verify whether the decline reflects new write-downs or a dividend cut |
These are analytical reference levels, valid only with intact assumptions. They are not configured alerts.
What Would Change the Assessment?
The thesis holds if NAV remains resilient after distributions, income covers the regular dividend over time and losses do not consume the low-cost advantage. The thesis would be invalidated by a combination of persistent payout undercoverage, rising troubled loans and repeated NAV declines per share.
Current View
Business strength: 7.2/10. Assessed on: November 4, 2026. Methodology: 1.2.
| Area | Score | Main evidence |
|---|---|---|
| Competitive advantage | 6.8/10 | Internal operating expenses of 1.4%, wider origination reach and 1,600 opportunities screened over 12 months; the advantage is documented but the market remains competitive. T3. |
| Demand durability | 7.7/10 | Record new commitments of USD 391 million across industries; acquisition and growth financing remains cyclical. T3, September 2026. |
| Management execution | 7.8/10 | Successful financing and issuance above NAV, but weaker credits and a small NII-per-share increase prevent an improved rating. T3, S9. |
| Business economics | 6.7/10 | Loan yield of 10.9%, sequentially lower PIK share; total dividends still exceed accounting NII. T3, S9. |
| Financial resilience | 7.0/10 | USD 647 million liquidity and no maturities before 2029, balanced by 1.00× regulatory leverage and 1.4% non-accruals at fair value. T3. |
The arithmetic mean of the five equally weighted areas is 7.2/10. Stock price is excluded. The overall score is unchanged: better evidence of origination strength is offset by higher leverage and credit problems.
- Brief rationale: record new business confirms platform strength, and financing has a longer horizon. However, the weaker portfolio segment deteriorated and asset growth still substantially outpaces income growth per share. Results support continuation of the thesis, not an upgrade to an exceptionally resilient company.
- Main weakness: tight regular-dividend coverage amid rising troubled loans and leverage at the upper end of the target.
- Assessment confidence: medium. Complete results, the 10-Q and transcript are available; future recoveries on troubled loans and JV income remain uncertain.
- Condition for change: two quarters of full regular-dividend coverage by after-tax accounting NII, stable NAV and no further non-accrual growth would support a higher score. Continued write-downs, non-accruals above 2% at fair value or persistently above-target leverage would lead to a downward revision. Thresholds are analytical monitoring criteria.
Thesis History / Updates
| Date | Methodology | Business strength | Price attractiveness | Price and quote date | Reason |
|---|---|---|---|---|---|
| October 17, 2026 | 1.2 | 7.2/10 | 5.7/10 | USD 23.08; October 16, 2026 | Initial analysis; dividend focus, complete June results and preliminary September figures |
| November 4, 2026 | 1.2 | 7.2/10 | 5.6/10 | USD 23.25; November 3, 2026 | Complete Q2 2027 results and new transcript: record new commitments and higher UTI are balanced by rising non-accruals and leverage. Strength unchanged; attractiveness slightly lower due to price and credit risks. |
Principal sources for both scores: new transcript T3, complete September results S9, filing S10 and current quote S8, read November 4, 2026. Earlier sources below provide comparison and context.
- T1: Supplied “Capital Southwest (CSWC) Q1 2027 Earnings Call Transcript,” call August 4, 2026, period ended June 30, 2026. Business, portfolio, expenses, UTI, PIK, capital and CapTrin.
- T2: Supplied October 15, 2026 preliminary-results announcement. Historical evidence, replaced in the current assessment by complete results S9.
- T3: Supplied “Capital Southwest (CSWC) Q2 2027 Earnings Call November 3, 2026,” call November 3, 2026, period ended September 30, 2026. Prepared remarks and Q&A; principal new supplied source.
- S9 Complete Q2 2027 results: released November 2, 2026; period ended September 30, 2026. Accounting results, NAV, non-accruals, dividends and financing.
- S10 Form 10-Q: quarter ended September 30, 2026, published November 2026. Results tables, portfolio structure and notes on financing and the interest-rate swap.
- S1 June results: published August 3, 2026; fiscal Q1 2027.
- S2 Preliminary September results: published October 15, 2026; historical preliminary estimate, replaced by S9.
- S3 Dividend declaration: published August 27, 2026; October–December 2026 payments.
- S4 Credit facility: September 2, 2026.
- S4b SBIC II capacity: September 17, 2026.
- S5 Note offering pricing: September 10, 2026.
- S6 Authorized shares: September 1, 2026.
- S7 Fiscal 2026 results: period ended March 31, 2026; comparative NAV and pre-tax NII for the March quarter.
- S8 Stock Analysis: CSWC common-stock closing quote of USD 23.25 on November 3, 2026 at 16:00 EST, data from S&P Global Market Intelligence. Verified November 4, 2026; closing price is distinguished from after-hours trading.
Limitations and discrepancies: where transcript commentary differs from an accounting metric, the relevant filing table takes precedence; the overview uses reported after-tax NII of USD 0.56 per share. Accounting NII, taxable income and realized gains are not interchangeable. Future timing of larger equity exits, JV returns and possible dividend growth are management expectations. Scenarios use no independent consensus and do not automatically translate overall portfolio growth into share-price growth.
Evidence confidence: high for published September data and the current quote, medium for interpretation of the credit cycle and future income. Investment-assessment status: the thesis continues with greater monitoring of credit losses and dividend coverage. ChatGPT assumptions cover future NAV, NII, total dividends and the valuation premium; future fully diluted market capitalization is not forecast separately.
Was this analysis useful to you?